The U.S. Food and Drug Administration has authorized the use of CLEW Medical's artificial intelligence tool to predict hemodynamic instability in adult patients in intensive care units.The tool,CLEWICU, uses AI-based algorithms and machine learning models to identify the likelihood of occurrence of significant clinical events for ICU patients.
the system notifies users of clinical deterioration up to eight hours in advance, enabling early intervention. The system also identifies low-risk patients who are unlikely to deteriorate,thus potentially enabling better ICU resource management and optimization.
【MORE】